IN191311B - - Google Patents

Info

Publication number
IN191311B
IN191311B IN48MU2000DA IN191311B IN 191311 B IN191311 B IN 191311B IN 48MU2000D A IN48MU2000D A IN 48MU2000DA IN 191311 B IN191311 B IN 191311B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Susan Jane Corvari
Joseph Richard Creekmore
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Publication of IN191311B publication Critical patent/IN191311B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IN48MU2000D 1997-12-18 2000-05-31 IN191311B (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9726735.5A GB9726735D0 (en) 1997-12-18 1997-12-18 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
IN191311B true IN191311B (ja) 2003-11-22

Family

ID=10823809

Family Applications (1)

Application Number Title Priority Date Filing Date
IN48MU2000D IN191311B (ja) 1997-12-18 2000-05-31

Country Status (30)

Country Link
US (1) US6399104B1 (ja)
EP (1) EP1041966B1 (ja)
JP (1) JP2001526206A (ja)
KR (1) KR20010033206A (ja)
CN (1) CN1282244A (ja)
AR (1) AR017884A1 (ja)
AT (1) ATE243999T1 (ja)
AU (1) AU744326C (ja)
BR (1) BR9813666A (ja)
CA (1) CA2313163A1 (ja)
DE (1) DE69816124T2 (ja)
DK (1) DK1041966T3 (ja)
EE (1) EE04260B1 (ja)
ES (1) ES2202915T3 (ja)
GB (1) GB9726735D0 (ja)
HU (1) HUP0004669A3 (ja)
ID (1) ID25857A (ja)
IL (1) IL136501A0 (ja)
IN (1) IN191311B (ja)
MY (1) MY133096A (ja)
NO (1) NO20003141L (ja)
NZ (1) NZ504566A (ja)
PL (1) PL341736A1 (ja)
PT (1) PT1041966E (ja)
RU (1) RU2205006C2 (ja)
SK (1) SK9402000A3 (ja)
TR (1) TR200001713T2 (ja)
UA (1) UA62991C2 (ja)
WO (1) WO1999032082A2 (ja)
ZA (1) ZA9811532B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO319624B1 (no) 2003-09-15 2005-09-05 Trouw Internat Bv Fiskefôr for laksefisk i ferskvann og anvendelse av slikt fôr.
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
DE102006006532B4 (de) * 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmazeutische Zubereitung
CA2660086C (en) * 2006-08-16 2014-09-16 Novartis Ag Method of making solid dispersions of highly crystalline therapeutic compounds
JPWO2008117814A1 (ja) * 2007-03-26 2010-07-15 帝國製薬株式会社 大腸送達用経口製剤
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
WO2018140858A1 (en) 2017-01-30 2018-08-02 Western New England University Thiol isomerases inhibitors and use thereof
CN107714694A (zh) * 2017-11-01 2018-02-23 天津国际生物医药联合研究院 扎鲁司特在抗结核分枝杆菌感染中的应用
WO2022243942A1 (en) 2021-05-19 2022-11-24 Quercis Pharma AG Quercetin-containing compositions for use in treating amyotrophic lateral sclerosis
WO2023214391A1 (en) 2022-05-06 2023-11-09 Quercis Pharma AG Method for treating cancers and neurological diseases using quercetin-containing compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds

Also Published As

Publication number Publication date
NO20003141D0 (no) 2000-06-16
HUP0004669A1 (hu) 2001-08-28
ID25857A (id) 2000-11-09
DE69816124D1 (de) 2003-08-07
CN1282244A (zh) 2001-01-31
US6399104B1 (en) 2002-06-04
HUP0004669A3 (en) 2005-03-29
EP1041966B1 (en) 2003-07-02
NZ504566A (en) 2002-10-25
TR200001713T2 (tr) 2000-10-23
NO20003141L (no) 2000-06-16
EP1041966A2 (en) 2000-10-11
MY133096A (en) 2007-10-31
ZA9811532B (en) 1999-06-18
AU744326C (en) 2002-11-07
ES2202915T3 (es) 2004-04-01
DK1041966T3 (da) 2003-10-06
AU1571199A (en) 1999-07-12
AR017884A1 (es) 2001-10-24
RU2205006C2 (ru) 2003-05-27
IL136501A0 (en) 2001-06-14
BR9813666A (pt) 2000-10-10
AU744326B2 (en) 2002-02-21
EE200000330A (et) 2001-08-15
SK9402000A3 (en) 2001-01-18
EE04260B1 (et) 2004-04-15
GB9726735D0 (en) 1998-02-18
JP2001526206A (ja) 2001-12-18
DE69816124T2 (de) 2004-05-06
WO1999032082A3 (en) 1999-09-16
PL341736A1 (en) 2001-05-07
ATE243999T1 (de) 2003-07-15
WO1999032082A2 (en) 1999-07-01
PT1041966E (pt) 2003-11-28
CA2313163A1 (en) 1999-07-01
KR20010033206A (ko) 2001-04-25
UA62991C2 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
BE2018C032I2 (ja)
DE69839117D1 (ja)
ITMI971348A0 (ja)
IN191899B (ja)
CH0944937H2 (ja)
JP2001515958A5 (ja)
IN191311B (ja)
ITMI971179A0 (ja)
BE2013C047I2 (ja)
BR9700653A (ja)
BR9701757A (ja)
ITPE970012V0 (ja)
IN185087B (ja)
ITRM970115V0 (ja)
ITRM970427A0 (ja)
ITTO970497A0 (ja)
ITTR970005V0 (ja)
ITGE970047A0 (ja)
CN3054556S (ja)
BY4238C1 (ja)
CN3054162S (ja)
CN3053525S (ja)
CN3053500S (ja)
CN3053170S (ja)
CN3057730S (ja)